PALO ALTO, Calif.--(BUSINESS WIRE)--#AI--Uniphore, an early leader in Conversational Service Automation (CSA), has teamed up with global leaders, including Idiap...
New RPA and Agent Security Solutions Set a New Standard for Customer Service Amid Era of Remote Work and High...
GUANGZHOU, China--(BUSINESS WIRE)--#biosimilar--Bio-Thera Solutions (SHA: 688177), a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
World-class scientists and physicians from Fred Hutchinson Cancer Research Center, St. Jude Children’s Research Hospital, Massachusetts General Hospital and Harvard...
Digiarty Software, Inc. (WinXDVD) is pleased to announce the availability of WinX MediaTrans v7.3, the next-generation iPhone manager with a...
Two leaders in case management software will combine to accelerate technology innovation for social good organizations AUSTIN, Texas--(BUSINESS WIRE)--Social Solutions...
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients...
XpresCheck testing facilities support new rapid testing requirements for select flights with United, Delta and KLM from JFK, Newark and...
Oracle Database licensees may consider using third-party support to provide better, more cost-efficient support and extend the lifespan of current...
With its facial recognition solution FaceMe®, CyberLink ranks first1 among global vendors in the latest NIST FRVT WILD test TAIPEI,...
BOSTON--(BUSINESS WIRE)--$TUFN #automation--Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced the appointment...
CHICAGO--(BUSINESS WIRE)--BAI announced the finalists for the 2020 BAI Global Innovation Awards, the industry’s prestigious awards program that celebrates new...
NEW YORK & LONDON & HONG KONG & TORONTO & GENEVA--(BUSINESS WIRE)--Options, the leading provider of cloud-enabled managed services to...
Mobocertinib, an oral targeted therapy, demonstrated clinically meaningful responses, with a confirmed objective response rate of 35% as assessed by...
OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced that the lead investigator of the Company’s NIPU Phase II clinical...
